000 | 01997 a2200577 4500 | ||
---|---|---|---|
005 | 20250516003051.0 | ||
264 | 0 | _c20101104 | |
008 | 201011s 0 0 eng d | ||
022 | _a1945-7170 | ||
024 | 7 |
_a10.1210/en.2010-0420 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAntoon, James W | |
245 | 0 | 0 |
_aAntiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640. _h[electronic resource] |
260 |
_bEndocrinology _cNov 2010 |
||
300 |
_a5124-35 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdamantane _xanalogs & derivatives |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aEstradiol _xmetabolism |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGene Expression _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
650 | 0 | 4 |
_aPhosphotransferases (Alcohol Group Acceptor) _xantagonists & inhibitors |
650 | 0 | 4 |
_aPyridines _xpharmacology |
650 | 0 | 4 |
_aReceptors, Estrogen _xgenetics |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
700 | 1 | _aWhite, Martin D | |
700 | 1 | _aMeacham, William D | |
700 | 1 | _aSlaughter, Evelyn M | |
700 | 1 | _aMuir, Shannon E | |
700 | 1 | _aElliott, Steven | |
700 | 1 | _aRhodes, Lyndsay V | |
700 | 1 | _aAshe, Hasina B | |
700 | 1 | _aWiese, Thomas E | |
700 | 1 | _aSmith, Charles D | |
700 | 1 | _aBurow, Matthew E | |
700 | 1 | _aBeckman, Barbara S | |
773 | 0 |
_tEndocrinology _gvol. 151 _gno. 11 _gp. 5124-35 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1210/en.2010-0420 _zAvailable from publisher's website |
999 |
_c20191189 _d20191189 |